EFPIA data: Multiple factors leading to unequal access to medicines in Europe
Three reports published by EFPIA show that disparities in the time it takes for European patients to access new medicines persist. Across the region, the average time to patient access is 531 days. Ranging from 126 days in Germany to 804 days in neighbouring Poland.